Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort.
Kobayashi M, Ferreira JP, Duarte K, Bresso E, Huttin O, Bozec E, Brunner La Rocca HP, Delles C, Clark AL, Edelmann F, González A, Heymans S, Pellicori P, Petutschnigg J, Verdonschot JAJ, Rossignol P, Cleland JGF, Zannad F, Girerd N; HOMAGE Trial Committees and Investigators. Kobayashi M, et al. Among authors: rossignol p. Eur J Heart Fail. 2024 May;26(5):1231-1241. doi: 10.1002/ejhf.3202. Epub 2024 Mar 25. Eur J Heart Fail. 2024. PMID: 38528728 Clinical Trial.
Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure.
Radauceanu A, Ducki C, Virion JM, Rossignol P, Mallat Z, McMurray J, Van Veldhuisen DJ, Tavazzi L, Mann DL, Capiaumont-Vin J, Li M, Hanriot D, Zannad F. Radauceanu A, et al. Among authors: rossignol p. J Card Fail. 2008 Aug;14(6):467-74. doi: 10.1016/j.cardfail.2008.02.014. Epub 2008 May 27. J Card Fail. 2008. PMID: 18672194 Clinical Trial.
Extracellular matrix fibrotic markers in heart failure.
Zannad F, Rossignol P, Iraqi W. Zannad F, et al. Among authors: rossignol p. Heart Fail Rev. 2010 Jul;15(4):319-29. doi: 10.1007/s10741-009-9143-0. Heart Fail Rev. 2010. PMID: 19404737 Review.
Vascular effects of cardiotrophin-1: a role in hypertension?
Lopez-Andres N, Fortuno MA, Diez J, Zannad F, Lacolley P, Rossignol P. Lopez-Andres N, et al. Among authors: rossignol p. J Hypertens. 2010 Jun;28(6):1261-72. doi: 10.1097/HJH.0b013e328337fe42. J Hypertens. 2010. PMID: 20216087
A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
López-Andrés N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V, Díez J. López-Andrés N, et al. Among authors: rossignol p. Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2372-82. doi: 10.1152/ajpheart.00283.2011. Epub 2011 Sep 16. Am J Physiol Heart Circ Physiol. 2011. PMID: 21926338 Free article.
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
Rossignol P, Ménard J, Fay R, Gustafsson F, Pitt B, Zannad F. Rossignol P, et al. J Am Coll Cardiol. 2011 Nov 1;58(19):1958-66. doi: 10.1016/j.jacc.2011.04.049. J Am Coll Cardiol. 2011. PMID: 22032706 Free article.
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
Lopez-Andrès N, Rossignol P, Iraqi W, Fay R, Nuée J, Ghio S, Cleland JG, Zannad F, Lacolley P. Lopez-Andrès N, et al. Among authors: rossignol p. Eur J Heart Fail. 2012 Jan;14(1):74-81. doi: 10.1093/eurjhf/hfr151. Epub 2011 Nov 16. Eur J Heart Fail. 2012. PMID: 22089058 Free article. Clinical Trial.
Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study.
Rossignol P, Cleland JG, Bhandari S, Tala S, Gustafsson F, Fay R, Lamiral Z, Dobre D, Pitt B, Zannad F. Rossignol P, et al. Circulation. 2012 Jan 17;125(2):271-9. doi: 10.1161/CIRCULATIONAHA.111.028282. Epub 2011 Nov 29. Circulation. 2012. PMID: 22128223 Clinical Trial.
Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes.
Neisius U, Bilo G, Taurino C, McClure JD, Schneider MP, Kawecka-Jaszcz K, Stolarz-Skrzypek K, Klima Ł, Staessen JA, Kuznetsova T, Redon J, Martinez F, Rosei EA, Muiesan ML, Melander O, Zannad F, Rossignol P, Laurent S, Collin C, Lonati L, Zanchetti A, Dominiczak AF, Delles C. Neisius U, et al. Among authors: rossignol p. J Hypertens. 2012 Jan;30(1):67-74. doi: 10.1097/HJH.0b013e32834e12d8. J Hypertens. 2012. PMID: 22134387
716 results